ANSI AAMI ST72-2019 PDF

Full title and description

ANSI/AAMI ST72:2019 — Bacterial endotoxins — Test methods, routine monitoring, and alternatives to batch testing. This AAMI recommended practice specifies general criteria for determining bacterial endotoxins on or in medical devices, components, or raw materials using bacterial endotoxin test (BET) methods (primarily Limulus amebocyte lysate reagents) and provides guidance on validation, routine monitoring, and acceptable alternatives to traditional batch testing.

Abstract

ST72:2019 describes the selection and use of BET methods (gel‑clot, turbidimetric and chromogenic/photometric techniques including kinetic variants), method suitability and validation, selection of product units and extraction conditions, interpretation of results, and options for process‑based or sampling‑based alternatives to full batch testing. The document is focused on bacterial endotoxins (not other pyrogens) and includes informative annexes on background, method guidance, out‑of‑specification investigations, and risk assessment for alternatives to batch testing.

General information

• Status: Current (ANSI/AAMI ST72:2019 is the active 2019 edition; earlier 2011(R2016) edition was superseded).
• Publication date: November 2019 (published November 2019).
• Publisher: Association for the Advancement of Medical Instrumentation (AAMI).
• ICS / categories: Medical microbiology; sterilization and disinfection; medical devices — (commonly associated ICS sectors for endotoxin/testing guidance include 07.100.10 and 11.080.01).
• Edition / version: ANSI/AAMI ST72:2019 (2019 edition).
• Number of pages: 65 pages (typical published PDF/page count).

Scope

Specifies general criteria to be applied in the determination of bacterial endotoxins on or in medical devices, components, or raw materials using BET methods that employ amebocyte lysate reagents (Limulus polyphemus or Tachypleus tridentatus). The standard is not applicable to pyrogens other than bacterial endotoxins; it covers selection of product units, extraction conditions, method suitability and validation, routine monitoring strategies, interpretation of results, and guidance on implementing alternatives to batch endotoxin testing (including risk assessment and process monitoring approaches).

Key topics and requirements

• Described BET techniques: gel‑clot (qualitative/limit), turbidimetric and chromogenic (quantitative), including kinetic photometric methods and requirements for standard curves and correlation.
• Method suitability and validation: demonstration of assay suitability with product extracts, controls, interference testing, maximum valid dilution (MVD) considerations, and documentation of validation activities.
• Selection of sample units and extraction: guidance on how many units to test, representative sampling, and extraction media/conditions appropriate to the device or material.
• Interpretation and limits: expressing limits as Endotoxin Units (EU) per device or per milliliter of extraction fluid and using appropriate calculation approaches to determine acceptance criteria.
• Alternatives to batch testing: risk‑based approaches, in‑process monitoring, statistical sampling, and justification of process controls as acceptable alternatives when supported by validated data.
• Recognition of alternative detection technologies: guidance on validating non‑LAL methods (for example recombinant Factor C) as equivalents where supported by data and method comparison.
• Informative annexes: background on BET, guidance on routine monitoring, investigation of OOS results, in‑process monitoring examples, and a risk‑assessment template for alternatives to batch testing.

Typical use and users

Used by medical device manufacturers, contract testing laboratories, sterilization and quality assurance professionals, regulatory affairs specialists, and clinical engineers involved in ensuring devices intended to be non‑pyrogenic meet endotoxin requirements. It guides bench testing, method validation, sampling strategies, and implementation of process‑based controls or alternative testing programs.

Related standards

References and aligns with other microbiological and sterilization standards and guidance (examples: ISO/IEC and ISO documents on sterilization and microbiological methods such as ISO 11737 series, USP <85> Bacterial Endotoxins, and relevant ISO standards for medical device sterilization and testing). Users typically consult companion documents on aseptic processing, water for processing (AAMI ST108), and regulatory guidance from FDA and pharmacopeias when applying ST72.

Keywords

bacterial endotoxins; BET; LAL; Limulus amebocyte lysate; recombinant Factor C; gel‑clot; turbidimetric; chromogenic; method suitability; validation; maximum valid dilution (MVD); endotoxin limits; non‑pyrogenic; medical devices; routine monitoring; alternatives to batch testing.

FAQ

Q: What is this standard?

A: ANSI/AAMI ST72:2019 is an AAMI recommended practice titled "Bacterial endotoxins — Test methods, routine monitoring, and alternatives to batch testing" that gives criteria and guidance for testing and monitoring bacterial endotoxins on or in medical devices and related materials.

Q: What does it cover?

A: It covers selection of test techniques (gel‑clot, turbidimetric, chromogenic and kinetic photometric methods), method suitability and validation, sample selection and extraction, interpretation of results and limits, routine monitoring approaches, investigation of out‑of‑specification (OOS) results, and risk‑based alternatives to full batch endotoxin testing. It excludes pyrogens other than bacterial endotoxins.

Q: Who typically uses it?

A: Medical device manufacturers, contract labs, QA/RA professionals, sterilization engineers, and laboratory personnel who perform or oversee endotoxin testing and validation programs.

Q: Is it current or superseded?

A: The 2019 edition (ANSI/AAMI ST72:2019) is the active 2019 edition and supersedes the 2011 (R2016) version. AAMI records show ongoing standards activity (e.g., committee ballots/reaffirmation activity in 2026), so users should check AAMI for any amendments, reaffirmations, or newer editions before relying on a specific clause for compliance.

Q: Is it part of a series?

A: ST72 is part of AAMI’s body of guidance on microbiological/sterilization topics and is often used alongside related AAMI standards and AAMI TIRs (technical information reports). It is frequently referenced with ISO and pharmacopeial endotoxin and sterilization standards when developing testing and validation programs.

Q: What are the key keywords?

A: Key keywords include bacterial endotoxins, BET, LAL, recombinant Factor C, gel‑clot, turbidimetric, chromogenic, method suitability, validation, MVD, endotoxin limits, non‑pyrogenic labeling, and alternatives to batch testing.